Tech Company Financing Transactions
Sionna Therapeutics Funding Round
OrbiMed, Atlas Venture and Cystic Fibrosis Foundation joined a $111 million Series B funding round for Sionna Therapeutics. The round closed on 4/21/2022.
Transaction Overview
Company Name
Announced On
4/21/2022
Transaction Type
Venture Equity
Amount
$111,000,000
Round
Series B
Investors
OrbiMed (Lead Investor) (Peter Thompson)
Proceeds Purpose
Intends to use the funds to advance development of a franchise of small molecules targeting NBD1
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
22 Strathmore Road
Natick, MA 01760
United States
Natick, MA 01760
United States
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Elena Ridloff
Chief Medical Officer
Charlotte McKee
Chief Scientific Officer
John Macor
Co-Founder
Greg Hurlbut
President
Mike Cloonan
Browse more venture capital transactions:
Prev: 4/21/2022: Wing Assistant venture capital transaction
Next: 4/21/2022: GLIDE venture capital transaction
Share this article
About Database of VC Transactions
We record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs